VCM
BPMC

Versant Capital Management’s Blueprint Medicines BPMC Stock Holding History

Versant Capital Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-103
Closed -$13.2K – 2648
2025
Q2 		$13.2K Buy
103
+56
+119% +$5.82K ﹤0.01% 1758
2025
Q1 		$4.16K Sell
47
-26
-36% -$2.54K ﹤0.01% 2091
2024
Q4 		$6.37K Buy
73
+63
+630% +$5.77K ﹤0.01% 1642
2024
Q3 		$925 Hold
10
– – ﹤0.01% 1765
2024
Q2 		$1.08K Hold
10
– – ﹤0.01% 1658
2024
Q1 		$949 Hold
10
– – ﹤0.01% 1555
2023
Q4 		$922 Hold
10
– – ﹤0.01% 1535
2023
Q3 		$502 Hold
10
– – ﹤0.01% 1692
2023
Q2 		$632 Buy
+10
New +$544 ﹤0.01% 1758
2022
Q3 		– Sell
-5
Closed – – 1435
2022
Q2 		$0 Hold
5
– – ﹤0.01% 1451
2022
Q1 		$0 Buy
+5
New +$359 ﹤0.01% 1464
2019
Q4 		– Sell
-45
Closed -$3K – 1362
2019
Q3 		$3K Buy
+45
New +$3.89K ﹤0.01% 1071
2019
Q2 		– Sell
-7
Closed – – 1421
2019
Q1 		$0 Buy
+7
New +$517 ﹤0.01% 1565

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Versant Capital Management's BPMC Position: Q3 2025 in Review

Versant Capital Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 103 shares — an estimated $13.2K sold.

Versant Capital Management first reported a position in BPMC in Q1 2019 and held it in 13 quarters. The position peaked at $13.2K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Versant Capital Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Versant Capital Management sold 103 Blueprint Medicines shares in Q3 2025, an estimated $13.2K.
  • Versant Capital Management first reported a position in Blueprint Medicines in Q1 2019 and held it in 13 quarters.
  • Versant Capital Management's Blueprint Medicines position peaked at $13.2K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Versant Capital Management's 13F filing for Q3 2025, filed 27 Oct 2025.